Prognostic Impact of Monocyte to Lymphocyte Ratio in Clinical Outcome for Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
DOI:
https://doi.org/10.31661/gmj.v9i.1948Keywords:
Hepatocellular Carcinoma; Liver Neoplasm; Lymphocyte to Monocyte Ratio; Survival; Disease-Free SurvivalAbstract
Background: Lymphocyte to monocyte ratio (LMR) is a surrogate marker of systemic inflammation which is shown to be related to the patient’s survival in multiple malignancies. An important implication of this marker potentially is neoplasms in which there is no correlation between prognosis and histopathological staging and also has no reliable chemical markers associated with prognosis. Herein, this meta-analysis aimed to investigate the prognostic role of LMR in patients with hepatocellular carcinoma (HCC). Materials and Methods: In the current systemic review and meta-analysis, we conducted a systemic search of databases and indexing sources, including PubMed, EMBASE, Cochrane, Scopus, and ProQuest up to May 2019 toinclude studies on the prognostic significance of LMR on patients with HCC. Overall survival (OS), disease-free survival (DFS) and recurrence-free survival (RFS) values were extracted from the studies and analyzed. The pooled hazard ratio with a 95% confidence interval was explored to identify the prognostic value of the LMR in the survival of the patients with HCC. Results: A total of 12 studies with a total sample size of 3750 cases were included. There was significant heterogeneity among the studies; therefore, subgroup analysis was also performed. Overall analysis regarding OS showed an insignificant relationship between LMR and patient’s prognosis, dividing to subgroups based on LMR cut-offs did not yield any significant result, subgroup analysis for RFS founded statistically significant results and LMR was significantly related to DFS. Conclusion: High LMR was associated with increased DFS and RFS, in return this association was not observed for OS. [GMJ.2020;9:e1948]
References
Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis. J Carcinog. 2017;16:1. https://doi.org/10.4103/jcar.JCar_9_16PMid:28694740 PMCid:PMC5490340 Yu LX, Ling Y, Wang HY. Role of nonresolving inflammation in hepatocellular carcinoma development and progression. NPJ Precis Oncol. 2018;2(1):6. https://doi.org/10.1038/s41698-018-0048-zPMid:29872724 PMCid:PMC5871907 Volcic M, Karl S, Baumann B, Salles D, Daniel P, Fulda S, et al. NF-κB regulates DNA double-strand break repair in conjunction with BRCA1-CtIP complexes. Nucleic Acids Res. 2012;40(1):181-95. https://doi.org/10.1093/nar/gkr687PMid:21908405 PMCid:PMC3245919 Taniguchi K, Karin M. NF-kappaB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309-24. https://doi.org/10.1038/nri.2017.142PMid:29379212 Adam JK, Odhav B, Bhoola KD. Immune responses in cancer. Pharmacol Ther. 2003;99(1):113-32. https://doi.org/10.1016/S0163-7258(03)00056-1 Chen G, Zhu L, Yang Y, Long Y, Li X, Wang Y. Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis. Technol Cancer Res Treat. 2018;17:1533033818791500. https://doi.org/10.1177/1533033818791500PMid:30145940 PMCid:PMC6111397 Zhao J, Huang W, Wu Y, Luo Y, Wu B, Cheng J, et al. Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis. Cancer cell international. 2020;20:15-. https://doi.org/10.1186/s12935-020-1094-5PMid:31938023 PMCid:PMC6954501 Liu L, Gong Y, Zhang Q, Cai P, Feng L. Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis. Front Oncol. 2019;9:1557. https://doi.org/10.3389/fonc.2019.01557PMid:32064238 PMCid:PMC7000550 Mao Y, Chen D, Duan S, Zhao Y, Wu C, Zhu F, et al. Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis. Cancer Cell Int. 2018;18:201. https://doi.org/10.1186/s12935-018-0698-5PMid:30534002 PMCid:PMC6282251 Li J, Cheng Y, Ji Z. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: A PRISMA-compliant meta-analysis. Medicine. 2019;98(2):e14091. https://doi.org/10.1097/MD.0000000000014091PMid:30633220 PMCid:PMC6336582 Wells G. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. http://wwwohrica/programs/clinical_epidemiologyoxfordhtm. 2004. Djordjevic D, Rondovic G, Surbatovic M, Stanojevic I, Udovicic I, Andjelic T, et al. Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia? Mediators Inflamm. 2018;2018:3758068. https://doi.org/10.1155/2018/3758068PMid:30116146 PMCid:PMC6079471 Badalamenti G, Fanale D, Incorvaia L, Barraco N, Listi A, Maragliano R, et al. Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? Cell Immunol. 2019;343. https://doi.org/10.1016/j.cellimm.2018.01.013PMid:29395859 Green AR, Aleskandarany MA, Ali R, Hodgson EG, Atabani S, De Souza K, et al. Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast Cancers. Cancer Immunol Res. 2017;5(4):292-9. https://doi.org/10.1158/2326-6066.CIR-16-0195PMid:28254786 Riabov V, Gudima A, Wang N, Mickley A, Orekhov A, Kzhyshkowska J. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Frontiers in physiology. 2014;5:75-. https://doi.org/10.3389/fphys.2014.00075PMid:24634660 PMCid:PMC3942647 Aras S, Zaidi MR. TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer. 2017;117(11):1583-91. https://doi.org/10.1038/bjc.2017.356PMid:29065107 PMCid:PMC5729447 Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Hatano T, et al. Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer. BMC Cancer. 2018;18(1):1137. https://doi.org/10.1186/s12885-018-5051-9PMid:30453914 PMCid:PMC6245848 Kano S, Homma A, Hatakeyama H, Mizumachi T, Sakashita T, Kakizaki T, et al. Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer. Head Neck. 2017;39(2):247-53. https://doi.org/10.1002/hed.24576PMid:27617428 Song W, Tian C, Wang K, Zhang R-J, Zou S-B. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: A meta-analysis. Scientific reports. 2017;7:46601-. https://doi.org/10.1038/srep46601PMid:28417972 PMCid:PMC5394547 Gong J, Jiang H, Shu C, Hu M-Q, Huang Y, Liu Q, et al. Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis. Journal of ovarian research. 2019;12(1):51-. https://doi.org/10.1186/s13048-019-0527-zPMid:31151469 PMCid:PMC6544921 Zhang J, Chen L, Zhou R, Sun H, Liao Y, Liao W. Pretreatment lymphocyte monocyte ratio predicts long-term outcomes in patients with digestive system tumor: a meta-analysis. Gastroenterol Res Pract. 2016;2016:9801063. https://doi.org/10.1155/2016/9801063PMid:27594882 PMCid:PMC4993921 Zhang Y, Shi S-M, Yang H, Yang L-X, Wang Z, Li X-D, et al. Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection. J Cancer. 2019;10(2):494-503. https://doi.org/10.7150/jca.26890PMid:30719145 PMCid:PMC6360305 Liu L, Zhao Y, Jia J, Chen H, Bai W, Yang M, et al. The prognostic value of alpha-fetoprotein response for advanced-stage hepatocellular carcinoma treated with sorafenib combined with transarterial chemoembolization. Sci Rep. 2016;6:19851. https://doi.org/10.1038/srep19851PMid:26831408 PMCid:PMC4735679 Fatourou EM, Suddle AR, Heneghan MA. Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver transplantation. Hepatoma Res. 2018;4:63. https://doi.org/10.20517/2394-5079.2018.62 Carr BI, Pancoska P, Branch RA. Low alpha-fetoprotein hepatocellular carcinoma. J Gastroenterol Hepatol. 2010;25(9):1543-9. https://doi.org/10.1111/j.1440-1746.2010.06303.xPMid:20796153 Peng D, Lu J, Hu H, Li B, Ye X, Cheng N. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma. J Gastroint Surg. 2019:1-11. https://doi.org/10.1007/s11605-018-04086-9PMid:30671792 PMCid:PMC7026310 Zhao Y-J, Ju Q, Li G-C. Tumor markers for hepatocellular carcinoma. Mol Clin Oncol. 2013;1(4):593-8. https://doi.org/10.3892/mco.2013.119PMid:24649215 PMCid:PMC3915636 Passacquale G, Vamadevan P, Pereira L, Hamid C, Corrigall V, Ferro A. Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PloS one. 2011;6(10):e25595. https://doi.org/10.1371/journal.pone.0025595PMid:22022418 PMCid:PMC3192052 Lisman T. Platelet-neutrophil interactions as drivers of inflammatory and thrombotic disease. Cell Tissue Res. 2018;371(3):567-76. https://doi.org/10.1007/s00441-017-2727-4PMid:29178039 PMCid:PMC5820397 Lin Z-X, Ruan D-Y, Li Y, Wu D-H, Ma X-K, Chen J, et al. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection. World J Gastroenterol. 2015;21(38):10898. https://doi.org/10.3748/wjg.v21.i38.10898PMid:26478681 PMCid:PMC4600591 Wu SJ, Lin YX, Ye H, Li FY, Xiong XZ, Cheng NS. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy. J Surg Oncol. 2016;114(2):202-10. https://doi.org/10.1002/jso.24297PMid:27199001 Li G-J, Ji J-J, Yang F, Xu H-W, Bai Y. Preoperative lymphocyte-to-monocyte ratio predicts survival in primary hepatitis B virus-positive hepatocellular carcinoma after curative resection. Onco Targets Ther. 2017;10:1181. https://doi.org/10.2147/OTT.S110411PMid:28260933 PMCid:PMC5328305 Hong YF, Chen ZH, Wei L, Ma XK, Li X, Wen JY, et al. Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma. Oncol Lett. 2017;14(2):2089-96. https://doi.org/10.3892/ol.2017.6420PMid:28789436 PMCid:PMC5530031 Shi S, Chen Q, Ye L, Yin D, Li X, Dai Z, et al. Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy. Oncotarget. 2017;8(45):79366. https://doi.org/10.18632/oncotarget.18121PMid:29108315 PMCid:PMC5668048 Chen Z-H, Hong Y, Ma X-k, Li X, Wu D-h, Lin Q, et al. Identification of prognostic value of lymphocyte-to-monocyte ratio in patients with advanced HBV-associated hepatocellular carcinoma. Oncol Lett. 2016. https://doi.org/10.1200/jco.2016.34.4_suppl.206 Yang T, Zhu J, Zhao L, Mai K, Ye J, Huang S, et al. Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection. J Surg Oncol. 2017;115(6):718-28. https://doi.org/10.1002/jso.24549PMid:28127774 Conroy G, Salleron J, Belle A, Bensenane M, Nani A, Ayav A, et al. The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib. Oncotarget. 2017;8(56):95853. https://doi.org/10.18632/oncotarget.21401PMid:29221172 PMCid:PMC5707066 Yang Y-T, Jiang J-H, Yang H-J, Wu Z-j, Xiao Z-M, Xiang B-D. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection. Sci Rep. 2018;8(1):2535. https://doi.org/10.1038/s41598-018-20199-2PMid:29416061 PMCid:PMC5803218 Takagi Y, Shimizu T, Ishizuka M, Shiraki T, Mori S, Iso Y, et al. Preoperative lymphocyte-to-monocyte ratio is useful for stratifying the prognosis of HCC patients with low CLIP scores. HPB. 2018;20:S371-S2. https://doi.org/10.1016/j.hpb.2018.06.2637 Zhang L, Chen QG, Li SQ, Zhang J, Min QH, Gao QF, et al. Preoperative fibrinogen to prealbumin ratio as a novel predictor for clinical outcome of hepatocellular carcinoma. Future Oncol. 2019;15(1):13-22. https://doi.org/10.2217/fon-2018-0376PMid:30139267 Shimizu T, Ishizuka M, Park KH, Shiraki T, Sakuraoka Y, Mori S, et al. Preoperative lymphocyte-to-monocyte ratio is useful for stratifying the prognosis of hepatocellular carcinoma patients with a low Cancer of the Liver Italian Program score undergoing curative resection. Ann Gastroenterol Surg. 2019;3(3):325-35. https://doi.org/10.1002/ags3.12251PMid:31131362 PMCid:PMC6524078 Gilmore E, McCabe N, Kennedy RD, Parkes EE. DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy. J Oncol. 2019;2019:4325105. https://doi.org/10.1155/2019/4325105PMid:31320901 PMCid:PMC6607732 Ni L, Lu J. Interferon gamma in cancer immunotherapy. Cancer medicine. 2018;7(9):4509-16. https://doi.org/10.1002/cam4.1700PMid:30039553 PMCid:PMC6143921 Shen M, Wang J, Ren X. New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms. Front Immunol. 2018;9:470. https://doi.org/10.3389/fimmu.2018.00470PMid:29568299 PMCid:PMC5852074 Han Y, Guo W, Ren T, Huang Y, Wang S, Liu K, et al. Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis. Cancer Lett. 2019;440-441:116-25. https://doi.org/10.1016/j.canlet.2018.10.011PMid:30343113 Kondo M, Yamato M, Takagi R, Namiki H, Okano T. The regulation of epithelial cell proliferation and growth by IL-1 receptor antagonist. Biomaterials. 2013;34(1):121-9. https://doi.org/10.1016/j.biomaterials.2012.09.036PMid:23059003 Mancino A, Lawrence T. Nuclear factor-kappaB and tumor-associated macrophages. Clin Cancer Res. 2010;16(3):784-9. https://doi.org/10.1158/1078-0432.CCR-09-1015PMid:20103670 PMCid:PMC6485421 Hutchins AP, Diez D, Miranda-Saavedra D. The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges. Brief Funct Genomics. 2013;12(6):489-98. https://doi.org/10.1093/bfgp/elt028PMid:23943603 PMCid:PMC3838198 Wan S, Zhao E, Kryczek I, Vatan L, Sadovskaya A, Ludema G, et al. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology. 2014;147(6):1393-404. https://doi.org/10.1053/j.gastro.2014.08.039PMid:25181692 PMCid:PMC4253315
